PLK1 and cancer: The plasmid containing the Cas9 gene and the gene encoding sgRNA can be introduced into target cells to form the CRISPR–Cas9 gene knockout system, which can knock out the PLK1 gene of target cells, promote the apoptosis of cancer cells and inhibit the proliferation and migration of cancer cells [13,14].